{"doi":"10.1111\/j.1365-2788.2009.01180.x","coreId":"212834","oai":"oai:eprints.lse.ac.uk:25441","identifiers":["oai:eprints.lse.ac.uk:25441","10.1111\/j.1365-2788.2009.01180.x"],"title":"The treatment of challenging behaviour in intellectual disabilities: cost-effectiveness analysis","authors":["Romeo, Renee","Knapp, Martin","Tyrer, P.","Crawford, M.","Oliver-Africano, P."],"enrichments":{"references":[],"documentType":{"type":null}},"contributors":[],"datePublished":"2009-07","abstract":"Background: Antipsychotic drugs are used in the routine treatment of adults with intellectual disabilities (ID) and challenging behaviour in the UK despite limited evidence of their effectiveness. There is no evidence on their cost-effectiveness. Methods: The relative cost-effectiveness of risperidone, haloperidol and placebo in treating individuals with an ID and challenging behaviour was compared from a societal perspective in a 26-week, double-blind, randomised controlled trial. Outcomes were changes in aggression and quality of life. Costs measured all service impacts and unpaid caregiver inputs. Results: After 26 weeks, patients randomised to placebo had lower costs compared with those in the risperidone and haloperidol treatment groups. Aggression was highest for patients treated with risperidone and lowest for patients treated with haloperidol; however, quality of life was lowest for patients treated with haloperidol and highest for patients treated with risperidone. Conclusion: The treatment of challenging behaviour in ID with antipsychotic drugs is not a cost-effective option","downloadUrl":"","fullTextIdentifier":null,"pdfHashValue":null,"publisher":"Blackwell Publishing","rawRecordXml":"<record><header><identifier>\n    \n    \n      oai:eprints.lse.ac.uk:25441<\/identifier><datestamp>\n      2010-10-01T09:27:50Z<\/datestamp><setSpec>\n      74797065733D4445505453:4C53452D5341<\/setSpec><setSpec>\n      74797065733D43454E54524553:4C53455F52435F3536<\/setSpec><\/header><metadata><oai_dc:dc xmlns:oai_dc=\"http:\/\/www.openarchives.org\/OAI\/2.0\/oai_dc\/\" xmlns:dc=\"http:\/\/purl.org\/dc\/elements\/1.1\/\" xmlns:xsi=\"http:\/\/www.w3.org\/2001\/XMLSchema-instance\" xsi:schemaLocation=\"http:\/\/www.openarchives.org\/OAI\/2.0\/oai_dc\/ http:\/\/www.openarchives.org\/OAI\/2.0\/oai_dc.xsd\" ><dc:relation>\n    \n      \n        http:\/\/eprints.lse.ac.uk\/25441\/<\/dc:relation><dc:title>\n        The treatment of challenging behaviour in intellectual disabilities: cost-effectiveness analysis<\/dc:title><dc:creator>\n        Romeo, Renee<\/dc:creator><dc:creator>\n        Knapp, Martin<\/dc:creator><dc:creator>\n        Tyrer, P.<\/dc:creator><dc:creator>\n        Crawford, M.<\/dc:creator><dc:creator>\n        Oliver-Africano, P.<\/dc:creator><dc:subject>\n        RA Public aspects of medicine<\/dc:subject><dc:description>\n        Background: Antipsychotic drugs are used in the routine treatment of adults with intellectual disabilities (ID) and challenging behaviour in the UK despite limited evidence of their effectiveness. There is no evidence on their cost-effectiveness. Methods: The relative cost-effectiveness of risperidone, haloperidol and placebo in treating individuals with an ID and challenging behaviour was compared from a societal perspective in a 26-week, double-blind, randomised controlled trial. Outcomes were changes in aggression and quality of life. Costs measured all service impacts and unpaid caregiver inputs. Results: After 26 weeks, patients randomised to placebo had lower costs compared with those in the risperidone and haloperidol treatment groups. Aggression was highest for patients treated with risperidone and lowest for patients treated with haloperidol; however, quality of life was lowest for patients treated with haloperidol and highest for patients treated with risperidone. Conclusion: The treatment of challenging behaviour in ID with antipsychotic drugs is not a cost-effective option.<\/dc:description><dc:publisher>\n        Blackwell Publishing<\/dc:publisher><dc:date>\n        2009-07<\/dc:date><dc:type>\n        Article<\/dc:type><dc:type>\n        PeerReviewed<\/dc:type><dc:identifier>\n          Romeo, Renee and Knapp, Martin and Tyrer, P. and Crawford, M. and Oliver-Africano, P.  (2009) The treatment of challenging behaviour in intellectual disabilities: cost-effectiveness analysis.  Journal of Intellectual Disability Research, 53 (7).  pp. 633-643.  ISSN 0964-2633     <\/dc:identifier><dc:relation>\n        http:\/\/www3.interscience.wiley.com<\/dc:relation><dc:relation>\n        10.1111\/j.1365-2788.2009.01180.x<\/dc:relation><\/oai_dc:dc><\/metadata><\/record>","journals":null,"language":null,"relations":["http:\/\/eprints.lse.ac.uk\/25441\/","http:\/\/www3.interscience.wiley.com","10.1111\/j.1365-2788.2009.01180.x"],"year":2009,"topics":["RA Public aspects of medicine"],"subject":["Article","PeerReviewed"],"fullText":null}